HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 41 to 60 of 90
< previous   next >
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
articleMiya, Aika; Nakamura, Akinobu; Kameda, Hiraku; Nozu, Kandai; Miyoshi, Hideaki; Atsumi, TatsuyaGitelman's syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration A case report-Medicine-Jul-2019
articleMiya, Aika; Nakamura, Akinobu; Miyoshi, Hideaki; Kameda, Hiraku; Nomoto, Hiroshi; Nagai, So; Omori, Yuko; Hatanaka, Kanako C.; Kobayashi, Hiroyuki; Shimizu, Chikara; Atsumi, TatsuyaGlucose tolerance is improved following surgery for silent somatotroph adenoma-International Journal of Diabetes and Clinical Research-2015
articleCho, Kyu Yong; Miyoshi, Hideaki; Nakamura, Akinobu; Kurita, Takashi; Atsumi, TatsuyaHyponatremia can be a powerful predictor of the development of isolated ACTH deficiency associated with nivolumab treatment-Endocrine Journal-Feb-2017
articleNanjo, Kazuhiro; Nagai, So; Shimizu, Chikara; Tajima, Toshihiro; Kondo, Takuma; Miyoshi, Hideaki; Yoshioka, Narihito; Koike, TakaoIdentification and functional analysis of novel calcium-sensing receptor gene mutation in familial hypocalciuric hypercalcemia-Endocrine journal-Sep-2010
articleMiya, Aika; Nakamura, Akinobu; Cho, Kyu Yong; Kawata, Shinichiro; Nomoto, Hiroshi; Nagai, So; Sugawara, Hajime; Taneda, Shinji; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Takeuchi, Jun; Aoki, Shin; Kurihara, Yoshio; Atsumi, Tatsuya; Miyoshi, HideakiImpact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients type 2 diabetes treated with canagliflozin plus teneligliptin-Journal of Diabetes Investigation-10-Aug-2021
articleMiya, Aika; Nakamura, Akinobu; Miyoshi, Hideaki; Takano, Yoshinari; Sunagoya, Kana; Hayasaka, Koji; Shimizu, Chikara; Terauchi, Yasuo; Atsumi, TatsuyaImpact of Glucose Loading on Variations in CD4+ and CD8+ T Cells in Japanese Participants with or without Type 2 Diabetes-Frontiers in Endocrinology-20-Mar-2018
articleNomoto, Hiroshi; Miyoshi, Hideaki; Nakamura, Akinobu; Atsumi, Tatsuya; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; on behalf of SAIS Study GroupImpact of incretin-related agents on endothelial cell function-Clinical Trials in Degenerative Diseases-Jan-2017
articleOba-Yamamoto, Chiho; Takeuchi, Jun; Nakamura, Akinobu; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Y.; Atsumi, Tatsuya; Miyoshi, HideakiImpact of low-starch high-fiber pasta on postprandial blood glucose-Nutrition, Metabolism and Cardiovascular Diseases-Feb-2022
articleNakamura, Akinobu; Miyoshi, Hideaki; Kameda, Hiraku; Yamashita, Kumiko; Kurihara, YoshioImpact of sodium-glucose cotransporter 2 inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease with normoalbuminuria-Diabetology and metabolic syndrome-10-Jan-2020
articleMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Miyoshi, Hideaki; Atsumi, TatsuyaImpaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment-Journal of diabetes investigation-May-2021
articleCho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Omori, Kazuno; Tsuchida, Kazuhisa; Miya, Aika; Shigesawa, Ikumi; Tsuchida, Kenichi; Yanagiya, Shingo; Kameda, Hiraku; Yokoyama, Hiroki; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Nishimoto, Naoki; Atsumi, Tatsuya; Miyoshi, HideakiImproved Time in Range and Postprandial Hyperglycemia with Canagliflozin in Combination with Teneligliptin : Secondary Analyses of the CALMER study-Journal of Diabetes Investigation-10-Aug-2021
articleTakase, Takahiro; Nakamura, Akinobu; Yamamoto, Chiho; Nomoto, Hiroshi; Miya, Aika; Dannoura, Midori; Cho, Kyu Yong; Kurihara, Yoshio; Manda, Naoki; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiImprovement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes : A randomized controlled trial-Journal of Diabetes Investigation-May-2019
article (author version)Nomoto, Hiroshi; Kondo, Takuma; Miyoshi, Hideaki; Nakamura, Akinobu; Hida, Yoko; Yamashita, Ken-ichiro; Sharma, Arun J.; Atsumi, TatsuyaInhibition of Small Maf Function in Pancreatic β-Cells Improves Glucose Tolerance Through the Enhancement of Insulin Gene Transcription and Insulin Secretion-Endocrinology-Oct-2015
articleNakamura, Akinobu; Miyoshi, Hideaki; Ukawa, Shigekazu; Nakamura, Koshi; Nakagawa, Takafumi; Terauchi, Yasuo; Tamakoshi, Akiko; Atsumi, TatsuyaInverse correlation between serum high‐molecular‐weight adiponectin and proinsulin level in a Japanese population : the DOSANCO Health Study-Journal of Diabetes Investigation-Jan-2021
articleYamamoto, Chiho; Miyoshi, Hideaki; Ono, Kota; Sugawara, Hajime; Kameda, Reina; Ichiyama, Mei; Yamamoto, Kohei; Nomoto, Hiroshi; Nakamura, Akinobu; Atsumi, TatsuyaIpragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy-Endocrine Journal-Jun-2016
articleKawagishi, Naoki; Suda, Goki; Nakamura, Akinobu; Kimura, Megumi; Maehara, Osamu; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Izumi, Takaaki; Umemura, Machiko; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Kudo, Yusuke; Nishida, Mutsumi; Miyoshi, Hideaki; Sakamoto, NaoyaLiver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis-PLOS ONE-2018
articleUeki, Kohjiro; Tanizawa, Yukio; Nakamura, Jiro; Yamada, Yuichiro; Inagaki, Nobuya; Watada, Hirotaka; Shimomura, Iichiro; Nishimura, Rimei; Miyoshi, Hideaki; Abiko, Atsuko; Katagiri, Hideki; Hayashi, Michio; Shimada, Akira; Naruse, Keiko; Fujimoto, Shimpei; Fujiwara, Masazumi; Shikata, Kenichi; Okada, Yosuke; Araki, Eiichi; Yamazaki, Tsutomu; Kadowaki, TakashiLong-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes : a 3-year prospective, controlled, observational study (J-BRAND Registry)-BMJ Open Diabetes Research & Care-2021
articleHashimoto-Kameda, Reina; Cho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Omori, Kazuno; Nagai, So; Edagawa, Sachiko; Kawata, Shinichiro; Takeuchi, Jun; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiLowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: A multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study)-Diabetes research and clinical practice-Oct-2021
articleYamauchi, Yuki; Nakamura, Akinobu; Yokota, Takashi; Takahashi, Kiyohiko; Kawata, Shinichiro; Tsuchida, Kazuhisa; Omori, Kazuno; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Anzai, Toshihisa; Tanaka, Shinya; Terauchi, Yasuo; Miyoshi, Hideaki; Atsumi, TatsuyaLuseogliflozin preserves the pancreatic beta-cell mass and function in db/db mice by improving mitochondrial function-Scientific reports-13-Jun-2022
article (author version)Takahashi, Yuka; Kameda, Hiraku; Miya, Aika; Nomoto, Hiroshi; Cho, Kyu Yong; Nakamura, Akinobu; Nishimura, Hiroki; Kimura, Hirokazu; Suzuki, Masaru; Konno, Satoshi; Shimizu, Ai; Matsuno, Yoshihiro; Okamoto, Michinari; Motegi, Hiroaki; Iwata, Naoko; Fujisawa, Haruki; Suzuki, Atsushi; Sugimura, Yoshihisa; Miyoshi, Hideaki; Atsumi, TatsuyaLymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis-Pituitary-6-Apr-2023
Showing results 41 to 60 of 90
< previous   next >

 

Hokkaido University